In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.
about
Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analoguesThe anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineComparative activities of several nucleoside analogs against duck hepatitis B virus in vitroComparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogsInhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesisEvidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducksIn vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusInhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidinePenciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cellsIdentification of BMS-200475 as a potent and selective inhibitor of hepatitis B virusInhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivoLong-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo modelResistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine.Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks.Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycinInhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoThe carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liverDesign of new anti-viral agents for chronic hepatitis B virus infection.Humanized murine model for HBV and HCV using human induced pluripotent stem cells2',3'-dideoxy-3'-fluoroguanosine inhibits duck hepatitis B virus in vivo.Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells.Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model.Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine.Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.Sulfated polyanions do not inhibit duck hepatitis B virus infection.Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro.Review: Present and future directions in the treatment of chronic hepatitis B infection.The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.Current status of anti-HBV chemotherapy.New therapeutic strategies in the treatment of hepatitis B virus infection.M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection.In vivo antiviral effects of mismatched double-stranded RNA on duck hepatitis B virus.Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.
P2860
Q28321734-0716283B-E330-45D6-9068-1BE9713CD8FFQ28327158-7B439E06-7996-4BF8-AB06-57E8E75E5EA9Q28331174-07BAD060-7C2E-415C-A593-D12D1863564FQ28333667-E5887F13-D106-4B59-8AD4-275BB70BF8A7Q28335579-B561BB40-C27D-44D1-8A4C-B96EC35B71B0Q28369077-F012FAF7-DE92-4342-AF96-395108B47CF9Q28369279-CF20A69C-2A4F-4AF4-985D-B8ACA5E54CFFQ28378787-FCC311BF-7840-4628-A778-1FD316356085Q28378980-C0195FC9-1472-469C-91CC-E052B3BF21AEQ28379014-6CC53122-48EF-4753-909A-F8EA58120D61Q28379225-06E065D6-A8FD-48D3-8E4C-CD6F853BBB3AQ33698569-FA7E7FF3-9C52-4A23-9250-D2805B77DA34Q33751721-5B0C981F-C877-492B-9959-72F2C68F028DQ34299035-7ECDD750-4868-4B58-AED1-0095EA53CABCQ34317365-636F0D3B-0FEB-4405-A87A-583A678488BBQ34975067-38951C38-0B4B-4485-9A72-5156D89A006CQ35014297-4B04D628-E7BE-4D7B-A061-D9863B53B25CQ35101574-8CF533E0-F143-4717-90BF-5600C5751A2EQ35112005-B9082289-96E5-44FE-8F53-A586BE15A25FQ35122451-7B891111-38C8-4816-8CC9-8F262E0E8A21Q35122499-340709D3-22B7-4BDF-B830-59620AE32D91Q36627152-FC49BD43-1056-4503-82E2-F1237DB6282FQ36828546-4D0CA7F2-32CA-40BB-9B04-CEF5896903D9Q37065853-C229F9EF-7B91-4FC2-8CBC-62099A254CA8Q38465842-7BFA53DC-431E-45D5-8F4A-875C48BC53E1Q39867025-D437C250-1BD1-4232-9338-A19E591AE15FQ39882638-6BCC2038-D733-421C-A666-87196BF78453Q40043127-94E5B05B-5826-4284-91DA-67521B6E82F0Q40046553-F9CDF1E9-B4D4-4857-9415-72A85A61C062Q40088139-62823A6D-9855-4395-8066-FD5D33773A02Q40628677-9E3760BC-4EE2-4434-A1CB-C56DD25B8ACCQ40866538-378F2A7A-2A68-43D4-A9A3-FEA736566E5BQ41617758-4A491964-6F8E-4024-B56A-EEAC3F26C372Q41943886-4F3607D2-FEA7-45C8-BF91-EF61993042BCQ43850205-4B6A2E52-87A8-4764-B673-6CF58AE1E3D7Q45439916-971817A9-0557-4BEE-9061-DFBBF4E57344Q45778654-CDE26D70-6A0E-4E07-9B57-4E037D180987Q45780287-E6B0BA06-241C-4154-8022-FB0F4D4B228BQ45865049-07535D57-AE46-4DD0-9D76-5E4508B4420A
P2860
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@en
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@nl
type
label
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@en
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@nl
prefLabel
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@en
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@nl
P2093
P2860
P356
P1476
In vitro and in vivo compariso ...... to inhibit duck hepadnavirus.
@en
P2093
P2860
P304
P356
10.1128/AAC.33.3.336
P407
P577
1989-03-01T00:00:00Z